BRIEF published on 04/20/2026 at 07:35, 4 months 14 days ago Nicox Sets Deadline for June 2024 Warrants Exercise Warrants Shares Euronext Nicox Exercise Deadline
PRESS RELEASE published on 04/20/2026 at 07:30, 4 months 14 days ago Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 Nicox SA reminds warrant holders of the upcoming expiration date on June 19, 2026. The warrants, with ISIN code FR001400QEQ3, provide the right to subscribe to new shares at €0.275 per share Euronext Growth Paris Warrants Equity Offering Expiration Date Nicox SA
BRIEF published on 02/24/2026 at 07:35, 6 months 8 days ago Nicox Reveals Positive Phase 3 Results for NCX 470 at AGS Meeting Glaucoma Phase 3 Study NCX 470 Intraocular Pressure Therapeutic Profile
PRESS RELEASE published on 02/24/2026 at 07:30, 6 months 8 days ago Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting Nicox announces positive NCX 470 Phase 3 data on intraocular pressure lowering efficacy at 2026 American Glaucoma Society Annual Meeting Nicox NCX 470 Phase 3 Data Intraocular Pressure Glaucoma Society
BRIEF published on 02/16/2026 at 07:35, 6 months 16 days ago Nicox Receives Positive Feedback from FDA for NCX 470 NDA FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
BRIEF published on 02/16/2026 at 07:35, 6 months 16 days ago Nicox is preparing an NDA submission for NCX 470 following a positive FDA opinion FDA Glaucoma NDA Nicox NCX 470
PRESS RELEASE published on 02/16/2026 at 07:30, 6 months 16 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
BRIEF published on 02/12/2026 at 07:35, 6 months 20 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
BRIEF published on 02/10/2026 at 07:35, 6 months 22 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
PRESS RELEASE published on 02/10/2026 at 07:30, 6 months 22 days ago Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026 Nicox to present NCX 470 Phase 3 data at AGS Annual Meeting 2026 with podium presentations showcasing clinical study results and efficacy of the ophthalmic solution Clinical Study Ophthalmology Nicox NCX 470 AGS Annual Meeting 2026
Published on 09/04/2026 at 23:30, 3 hours 1 minute ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 hours 31 minutes ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 4 hours 1 minute ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 12 hours 1 minute ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 12 hours 31 minutes ago Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair
Published on 09/04/2026 at 22:10, 4 hours 20 minutes ago Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 7 hours 10 minutes ago Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 18:50, 7 hours 40 minutes ago A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset
Published on 09/04/2026 at 18:05, 8 hours 25 minutes ago Grundig Unveils New Product Lineup at IFA 2026, Marking a New Phase in Strategic Partnership
Published on 09/04/2026 at 18:57, 7 hours 34 minutes ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 8 hours 46 minutes ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 17:45, 8 hours 46 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 09/04/2026 at 16:00, 10 hours 31 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 10 hours 31 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
